Crespo J, Sun H, Wu J, Ding QQ, et al. Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy. PLoS One 2020;15:e0241775.
PMID: 33180796